Bit odd that they use a 5.8% concentrate as the benchmark, getting this from GXY i assume. Also the sales cost from GXY but like others said assuming this stays at $920 late into 2020 is just a bit silly.
Why were they not able to calculate the tin offset in the SS? i'm pretty confused as from many posters calculations that could reduce costs by up to 10%.
Good results all around though, shows profit on 2MTPA and hopefully the 5/10MTPA calculations don't take too long.
- Forums
- ASX - By Stock
- Ann: Scoping Study Highlights Strong Economic Potential of Manono
Bit odd that they use a 5.8% concentrate as the benchmark,...
-
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online